News/ R&D Chinese CAR-T results offer hope of myeloma cure Richard Staines ASCO 2017, blood cancer, bluebirdbio, cancer, CAR T, Celgene, Nanjing Biotech 0 Comment This year’s ASCO conference has plenty of data from the CAR-T therapy contenders – but little known Chinese Share X Chinese CAR-T results offer hope of myeloma cure https://pharmaphorum.com/news/chinese-biotech-delivers-car-t-surprise-asco/
ASCO 2017, blood cancer, bluebirdbio, cancer, CAR T, Celgene, Nanjing Biotech
0 Comment
